Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-25

Clinical Trial Update: Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of olopatadine hydrochloride and ketorolac tromethamine in an ophthalmic solution versus olopatadine alone for seasonal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)
  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)
  • Olopatadine hydrochloride/ketorolac tromethamine ophthalmic solution

Snippet

Sponsor: Allergan | Conditions: Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic | Phase 3 | Status: COMPLETED